Pseudomonas aeruginosa Biofilm Dispersion by the Human Atrial Natriuretic Peptide

Abstract

Pseudomonas aeruginosa biofilms cause chronic, antibiotic tolerant infections in wounds and lungs. Numerous recent studies demonstrate that bacteria can detect human communication compounds through specific sensor/receptor tools that modulate bacterial physiology. Consequently, interfering with these mechanisms offers an exciting opportunity to directly affect the infection process. It is shown that the human hormone Atrial Natriuretic Peptide (hANP) both prevents the formation of P. aeruginosa biofilms and strongly disperses established P. aeruginosa biofilms. This hANP action is dose‐dependent with a strong effect at low nanomolar concentrations and takes effect in 30–120 min. Furthermore, although hANP has no antimicrobial effect, it acts as an antibiotic adjuvant. hANP enhances the antibiofilm action of antibiotics with diverse modes of action, allowing almost full biofilm eradication. The hANP effect requires the presence of the P. aeruginosa sensor AmiC and the AmiR antiterminator regulator, indicating a specific mode of action. These data establish the activation of the ami pathway as a potential mechanism for P. aeruginosa biofilm dispersion. hANP appears to be devoid of toxicity, does not enhance bacterial pathogenicity, and acts synergistically with antibiotics. These data show that hANP is a promising powerful antibiofilm weapon against established P. aeruginosa biofilms in chronic infections.

Effect of Phthalates and Their Substitutes on the Physiology of Pseudomonas aeruginosa

“…The molecular mechanisms leading to these phenotypes upon phthalate or substitute exposure could be different from one compound to another and will require further investigations to be deciphered. However, since P. aeruginosa is able to sense human hormones such as the natriuretic peptides [37,83], dynorphin [38], serotonin [84], epinephrine [39], or estradiol [41,42], for example, and since phthalates are considered as xenoestrogens, it is possible that P. aeruginosa can sense and respond to such compounds by adjusting its behavior and physiology.…”

Pseudomonas aeruginosa biofilm dispersion by the mouse antimicrobial peptide CRAMP

“…P. aeruginosa has been classified as an antimicrobial-resistant ESKAPE ( Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae, Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter spp.) pathogen [ 10 ]. In 2017, the World Health Organization listed P. aeruginosa as one of the most critical pathogens for which a new antibiotic is urgently needed [ 2 , 3 ].…”

Brain Natriuretic Peptide (BNP) Affects Growth and Stress Tolerance of Representatives of the Human Microbiome, Micrococcus luteus C01 and Alcaligenes faecalis DOS7

“…Usually, most studies related to the effect of HRF on human symbiont bacteria are aimed at studying changes in their virulence, antibiotic resistance, and the ability to form persister cells or biofilms [ 50 , 51 , 52 , 53 ]. For example, in Ref.…”